
13/02/2020
KANSAS CITY, Mo. — Erythropoietin stimulating agent use can be reduced with improved nutrition and increased use of vitamin D in patients on hemodialysis, according to results of a study presented at The Annual Dialysis Conference. “Micronutrient and vitamin D deciency reduces survival,....